Trial Profile
A Three-part First Time in Human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Food Effect of Single Oral Doses of GSK580416 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2023
Price :
$35
*
At a glance
- Drugs GSK 580416 (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 08 Jun 2012 New trial record